Search Results
Apr 29, 2026, 21:37 ET 하이크비전, 2025년 연간 및 2026년 1분기 재무 결과 발표
하이크비전 발전의 원동력으로 남아 있다. 2025년 회사는 연구개발에 총매출의 12.70%에 해당하는 117억 5000만 위안(16억 5000만 달러)을 투자했다. 지난 6년간 누적 연구개발 투자는 80억 달러를 초과했으며, 연간 매출의 10% 이상을 지속적으로 R&D에 투입했다.이러한 지속적인 투자는 회사의 지식재산권 포트폴리오를 강화했다. 2025년 말 기준 하이크비전은 전 세계적으로 1만 2981건의 승인된 특허를 축적했으며, 이 중 발명 특허가 57%를 차지했다.전망올해
More news about: Hikvision
Apr 29, 2026, 21:16 ET LG Energy Solution Releases 2026 First-Quarter Financial Results
IT, and energy storage systems. With more than 30 years of experience in revolutionary battery technology and extensive research and development (R&D), the company is the top battery-related patent holder in the world with over 90,000 patents. Its robust global network, which spans North America,
More news about: LG Energy Solution
Apr 29, 2026, 20:10 ET 歌禮將攜多個項目數據亮相美國糖尿病協會2026年度科學會議
(1672-P)日期/時間：2026年6月7日，周日，美國中部時間 (CT) 下午12:30標題：ASC37口服片（GLP-1R/GIPR/GCGR三靶點激動劑多肽）在非人靈長類動物研究中實現4.2%的平均絕對口服生物利用度 (ASC37 Oral Tablets, GLP-1R/GIPR/GCGR Triple Agonist Peptide, Achieved Average Absolute Oral Bioavailability of 4.2% in Nonhuman
More news about: 歌禮製藥有限公司
Apr 29, 2026, 20:10 ET Ascletis to Present Data on Multiple Programs at the American Diabetes Association's 2026 Scientific Sessions
molecule GLP-1R agonist designed to be administered once daily orally and once monthly to once quarterly subcutaneously as a treatment therapy and a maintenance therapy for chronic weight management; ASC36, an amylin receptor peptide agonist, ASC35, a once-monthly subcutaneously administered GLP-1R/GIPR dual
More news about: Ascletis Pharma Inc.
Apr 29, 2026, 18:53 ET FIBRA Prologis Anuncia sus Resultados Financieros del Primer Trimestre de 2026
https://mma.prnewswire.com/media/528012/4979844/FIBRA_Prologis_R1_Logo.jpg FUENTE FIBRA Prologis
More news about: FIBRA Prologis
Apr 29, 2026, 18:51 ET FIBRA Prologis Anuncia sus Resultados Financieros del Primer Trimestre de 2026
https://mma.prnewswire.com/media/528012/4979844/FIBRA_Prologis_R1_Logo.jpg
More news about: FIBRA Prologis
Apr 29, 2026, 18:30 ET AANA Presents U.S. Sen. Susan Collins with National Health Leadership Award
/PRNewswire/ -- (AANA) - The American Association of Nurse Anesthesiology (AANA) recognized U.S. Sen. Susan Collins (R-ME) as with its National Health Leadership Award for 2026 at its Mid-Year Assembly, April 24-29, in Washington, DC.
More news about: American Association of Nurse Anesthesiology
Apr 29, 2026, 18:13 ET /C O R R E C T I O N -- Bridgestone Americas, Inc./
More news about: Bridgestone Americas, Inc.
Apr 29, 2026, 17:16 ET MiTAC Computing sa vracia na OCP EMEA 2026 s novými servermi OCP chladenými kvapalinou a integráciou softvéru
centrách.A na záver, MiTAC R2520G6 je podnikový server vybavený dvoma procesormi Intel® Xeon® 6, až 32 modulmi DDR5-6400 RDIMM a škálovateľným úložiskom NVMe U.2 s podporou až 24 diskov.
More news about: MiTAC Computing Technology Corp.
Apr 29, 2026, 17:15 ET Yatsen Filed 2025 Annual Report on Form 20-F
and clinical segments. Yatsen thrives on the synergy of brand equity, product strength and operational agility, anchored by a strong commitment to R&D and consumer insights.For more information, please visit http://ir.yatsenglobal.com/.For
More news about: Yatsen Holding Limited
Apr 29, 2026, 17:15 ET Denecimig (Mim8) significantly reduced annualized bleeding rate in people with hemophilia A, regardless of inhibitor status, in phase 3 data published in NEJM
States, Novo Nordisk has a 40-year presence, is headquartered in New Jersey and employs approximately 10,000 people across more than 10 manufacturing, R&D, and corporate locations in seven states plus Washington, D.C. For more information, visit
More news about: Novo Nordisk
Apr 29, 2026, 17:11 ET MiTAC Computing возвращается на OCP EMEA 2026 с новыми серверами OCP с жидкостным охлаждением и интеграцией программного обеспечения
обработки данных.Наконец, MiTAC R2520G6 — это корпоративный сервер, оснащенный двумя процессорами Intel® Xeon® 6, до 32 модулей RDIMM DDR5-6400 и масштабируемой системой хранения NVMe U.2,
More news about: MiTAC Computing Technology Corp.
Apr 29, 2026, 17:07 ET MiTAC Computing powraca na OCP EMEA 2026 z ofertą nowych serwerów OCP chłodzonych cieczą i integracji oprogramowania
BARCELONA (Hiszpania), 29 kwietnia 2026 r. /PRNewswire/ -- MiTAC Computing Technology, globalny dostawca wysokowydajnych i energooszczędnych rozwiązań serwerowych i spółka zależna MiTAC Holdings Corporation (TWSE:3706), powraca
More news about: MiTAC Computing Technology Corp.
Apr 29, 2026, 17:07 ET Denecimig (Mim8) significantly reduced annualized bleeding rate in people with hemophilia A, regardless of inhibitor status, in phase 3 data published in NEJM
States, Novo Nordisk has a 40-year presence, is headquartered in New Jersey and employs approximately 10,000 people across more than 10 manufacturing, R&D, and corporate locations in seven states plus Washington, D.C. For more information, visit
More news about: Novo Nordisk
Apr 29, 2026, 17:01 ET MiTAC Computing regresa con novedades a OCP EMEA 2026
hiperescala.Por último, el MiTAC R2520G6 es un servidor empresarial equipado con dos procesadores Intel® Xeon® 6, hasta 32 módulos DDR5-6400 RDIMM y almacenamiento NVMe U.2 escalable compatible
More news about: MiTAC Computing Technology Corp.
Apr 29, 2026, 16:55 ET Greenberg Traurig's House Band, The Meltones, Plays It Forward for The Headstrong Project, Again Wins Law Rocks LA
Michael R. Hogue;
More news about: Greenberg Traurig, LLP
Apr 29, 2026, 16:10 ET /C O R R E C T I O N -- Brio Italian Grille/
More news about: Brio Italian Grille
Apr 29, 2026, 16:01 ET Soleno Therapeutics, Inc. (SLNO) Shareholders Who Lost Money Have Opportunity to Lead Securities Fraud Lawsuit
The Law Offices of Frank R. Cruz announces that investors with losses related to Soleno Therapeutics, Inc. ("Soleno" or the "Company") (NASDAQ:
More news about: The Law Offices of Frank R. Cruz, Los Angeles
Apr 29, 2026, 16:00 ET Novavax to Report First Quarter 2026 Financial Results on May 6, 2026
Company's growth strategy focuses on maximizing the impact of its cutting-edge technology by forging strategic partnerships for its Matrix-M adjuvant and R&D assets. Please visit
More news about: Novavax, Inc.
Apr 29, 2026, 15:47 ET INTCO Medical maakt resultaten over 2025 bekend met een veerkrachtige groei; omzet bereikt hoogste niveau in vier jaar nu de sector zich herstelt
productiecapaciteit versterken de kernactiviteitenWegwerphandschoenen bleven de kernactiviteit van INTCO Medical. Eind 2025 had het Bedrijf wereldwijd 10 R&D- en productielocaties, met een jaarlijkse capaciteit voor wegwerphandschoenen zonder latex van 103 miljard stuks, waaronder 70 miljard nitrilhandschoenen
More news about: INTCO MEDICAL
Apr 29, 2026, 15:37 ET Les coulisses de trois années de domination : l'expansion anticyclique d'Unilumin
transition, Unilumin a stratégiquement réduit certaines parties de ses activités traditionnelles d'éclairage tout en augmentant les investissements en R&D, particulièrement en intelligence artificielle. Il s'agit d'une nette transition de la dépendance à la vente de matériel vers un modèle plus intégré
More news about: Unilumin Group., Ltd.